Eyeworld

APR 2015

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/493807

Contents of this Issue

Navigation

Page 82 of 86

OVER 15 MILLION PROCEDURES AND COUNTING Helping you take more of your patients beyond 20/20* *20/16 results delivered with excimer laser, clinical studies send to FDA via P930016 supplement 021. Laser assisted in-situ keratomileusis (LASIK) can only be performed by a trained ophthalmologist and for speci ed reduction or elimination of myopia, hyperopia, and astigmatism as indicated within the product labeling. Laser refractive surgery is contraindicated for patients: a) with collagen vascular, autoimmune, or immunode ciency diseases; b) who are pregnant or nursing women; c) with signs of keratoconus or abnormal corneal topography; d) who are taking one or both of the following medications: Isotretinoin (Accutane) and Amiodarone hydrochloride (Cordarone). Potential side effects to laser refractive surgery may include glare, dry eye, as well as other visual anomalies. LASIK requires the use of a microkeratome that cuts a ap on the surface of the cornea, potential side effects may include ap related complications. Patients are requested to consult with their eye care professional and Patient Information Booklet regarding the potential risks and bene ts for laser refractive surgery, results may vary for each individual patient. Restricted Device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed eye care practitioner. U.S. Federal Law restricts the use of this device to practitioners who have been trained in its calibration and operation and who have experience in the surgical treatment and management of refractive errors. ©2014 Abbott Medical Optics Inc. iLASIK is a registered trademark owned by or licensed to Abbott Laboratories, its subsidiaries or af liates. 2011.04.26-RF3357 Only iLASIK Technology provides truly customized treatments to help you take more of your patients beyond 20/20. Scan this code or visit www.amo-ilasik.com/proven to learn how to bring proven technology, that's good enough for NASA, to your patients. Please see brief statement on adjacent page.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - APR 2015